Sirt1 protects against thrombomodulin down-regulation and lung coagulation after particulate matter exposure

Blood

Volumn 119, Issue 10, 2012, Pages 2422-2429

  Wu, Zhuang ^a   Liu, Ming Cheh ^b   Liang, Mei ^a   Fu, Jian ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; HISTONE DEACETYLASE; I KAPPA B; KRUPPEL LIKE FACTOR 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIRTUIN 1; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; DOWN REGULATION; ENZYME ACTIVITY; FIBRINOLYSIS; HISTONE ACETYLATION; KNOCKOUT MOUSE; LUNG BLOOD VESSEL; MOUSE; NONHUMAN; PARTICULATE MATTER; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 84858020464     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-350413     Document Type: Article

References (57)

1. Dales RE, Cakmak S, Vidal CB. Air pollution and hospitalization for venous thromboembolic disease in Chile. J Thromb Haemost. 2010;8(4):669-674.
2. Mutlu GM, Green D, Bellmeyer A, et al. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest. 2007; 117(10):2952-2961. (Pubitemid 47529625)
3. Bonzini M, Tripodi A, Artoni A, et al. Effects of inhalable particulate matter on blood coagulation. J Thromb Haemost. 2010;8(4):662-668.
4. Nemmar A, Al-Salam S, Dhanasekaran S, Sudhadevi M, Ali BH. Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel thrombosis: protective effect of a cysteine prodrug l-2-oxothiazolidine-4-carboxylic acid. Toxicology. 2009;263(2-3):84-92.
5. Emmerechts J, Alfaro-Moreno E, Vanaudenaerde BM, Nemery B, Hoylaerts MF. Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice. J Thromb Haemost. 2010;8(12):2651-2661.
6. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331-2378.
7. Soberanes S, Urich D, Baker CM, et al. Mitochondrial complex III-generated oxidants activate ASK1 and JNK to induce alveolar epithelial cell death following exposure to particulate matter air pollution. J Biol Chem. 2009;284(4):2176-2186.
8. Rhoden CR, Lawrence J, Godleski JJ, Gonzalez- Flecha B. N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci. 2004; 79(2):296-303. (Pubitemid 38786887)
9. Soberanes S, Panduri V, Mutlu GM, Ghio A, Bundinger GR, Kamp DW. p53 mediates particulate matter-induced alveolar epithelial cell mitochondria- regulated apoptosis. Am J Respir Crit Care Med. 2006;174(11):1229-1238. (Pubitemid 44924824)
10. Tamagawa E, Bai N, Morimoto K, et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol. 2008;295(1): L79-85.
11. Upadhyay D, Panduri V, Ghio A, Kamp DW. Particulate matter induces alveolar epithelial cell DNA damage and apoptosis: role of free radicals and the mitochondria. Am J Respir Cell Mol Biol. 2003;29(2):180-187. (Pubitemid 36936645)
12. Urich D, Soberanes S, Burgess Z, et al. Proapoptotic Noxa is required for particulate matter-induced cell death and lung inflammation. Faseb J. 2009;23(7):2055-2064.
13. Nurkiewicz TR, Porter DW, Barger M, et al. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect. 2006;114(3):412-419. (Pubitemid 43338267)
14. Budinger GR, McKell JL, Urich D, et al. Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms. PLoS One. 2011;6(4):e18525.
15. Gomez K, McVey JH. Tissue factor initiated blood coagulation. Front Biosci. 2006;11:1349-1359.
16. Westrick RJ, Eitzman DT. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets. 2007;8(9):966-1002.
17. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol. 2004;24(8):1374-1383. (Pubitemid 39050428)
18. Van de Wouwer M, Conway EM. Novel functions of thrombomodulin in inflammation. Crit Care Med. 2004;32(5 suppl):S254-261.
19. Conway EM, Van de Wouwer M, Pollefeyt S, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med. 2002;196(5):565-577. (Pubitemid 35024436)
20. Ding BS, Hong N, Christofidou-Solomidou M, et al. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation. Am J Respir Crit Care Med. 2009;180(3):247-256.
21. Lavu S, Boss O, Elliott PJ, Lambert PD. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov. 2008;7(10):841-853.
22. Cheng HL, Mostoslavsky R, Saito S, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A. 2003;100(19):10794-10799. (Pubitemid 37140107)
23. Pillarisetti S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov. 2008;3(3): 156-164.
24. Han L, Zhou R, Niu J, McNutt MA,Wang P, Tong T. SIRT1 is regulated by a PPAR-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 2010;38(21):7458-7471.
25. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an anti-inflammatory and anti-aging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(8):861-870. (Pubitemid 351600664)
26. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 2007;292(2):L567-576.
27. Lee JH, Song MY, Song EK, et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes. 2009;58(2):344-351.
28. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays. 2008;30(10):939-942.
29. Yang XD, Tajkhorshid E, Chen LF. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB. Mol Cell Biol. 2010;30(9):2170-2180.
30. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369-2380. (Pubitemid 38954844)
31. Song D, Ye X, Xu H, Liu SF. Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice. Blood. 2009; 114(12):2521-2529.
32. Sohn RH, Deming CB, Johns DC, et al. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 2005;105(10): 3910-3917. (Pubitemid 40656136)
33. Andersen ZJ, Wahlin P, Raaschou-Nielsen O, Ketzel M, Scheike T, Loft S. Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark. Occup Environ Med. 2008;65(7):458-466. (Pubitemid 351969696)
34. Li H, Rajendran GK, Liu N, Ware C, Rubin BP, Gu Y. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res. 2007;9(1):R1.
35. Cheng L, Guo J, Sun L, et al. Postnatal tissue-specific disruption of transcription factor FoxN1 triggers acute thymic atrophy. J Biol Chem. 2010; 285(8):5836-5847.
36. Huggins FE, Huffman GP, Robertson JD. Speciation of elements in NIST particulate matter SRMs 1648 and 1650. J Hazard Mater. 2000;74(1-2):1-23. (Pubitemid 30227266)
37. Orson FM, Song L, Gautam A, Densmore CL, Bhogal BS, Kinsey BM. Gene delivery to the lung using protein/polyethylenimine/plasmid complexes. Gene Ther. 2002;9(7):463-471. (Pubitemid 34428755)
38. Wu Z, Sawamura T, Kurdowska AK, Ji HL, Idell S, Fu J. LOX-1 deletion improves neutrophil responses, enhances bacterial clearance, and reduces lung injury in a murine polymicrobial sepsis model. Infect Immun. 2011;79(7):2865-2870.
39. Zhang P, Liu MC, Cheng L, Liang M, Ji HL, Fu J. Blockade of LOX-1 prevents endotoxin-induced acute lung inflammation and injury in mice. J Innate Immun. 2009;1(4):358-365.
40. Shin HS, Xu F, Bagchi A, et al. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J Immunol. 2011;186(2):1119-1130.
41. Johnson LL, Berggren KN, Szaba FM, Chen W, Smiley ST. Fibrin-mediated protection against infection-stimulated immunopathology. J Exp Med. 2003;197(6):801-806. (Pubitemid 36350874)
42. Potente M, Ghaeni L, Baldessari D, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21(20):2644-2658. (Pubitemid 47607673)
43. Mutlu GM, Snyder C, Bellmeyer A, et al. Airborne particulate matter inhibits alveolar fluid reabsorption in mice via oxidant generation. Am J Respir Cell Mol Biol. 2006;34(6):670-676. (Pubitemid 43825331)
44. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2011;38(2 suppl):26-34.
45. Liu SF, Malik AB. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol. 2006;290(4):L622-L645. (Pubitemid 43738989)
46. Zingarelli B, Sheehan M, Wong HR. Nuclear factor- kappaB as a therapeutic target in critical care medicine. Crit Care Med. 2003;31(1 suppl):S105-111. (Pubitemid 36143484)
47. Matsuda N, Yamamoto S, Takano K, et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med. 2009;179(9):806-815.
48. Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96(5):e48-57.
49. Kumar A, Lin Z, SenBanerjee S, Jain MK. Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Mol Cell Biol. 2005;25(14):5893-5903. (Pubitemid 40946546)
50. Zahlten J, Steinicke R, Opitz B, et al. TLR2-and nucleotide-binding oligomerization domain 2-dependent Kruppel-like factor 2 expression downregulates NF-kappa B-related gene expression. J Immunol. 2010;185(1):597-604.
51. Cozzi E, Wingard CJ, Cascio WE, et al. Effect of ambient particulate matter exposure on hemostasis. Transl Res. 2007;149(6):324-332. (Pubitemid 46818161)
52. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood. 2003;101(11):4387-4392. (Pubitemid 36857803)
53. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood. 1987;69(2):381-387. (Pubitemid 17022002)
54. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation. 2002; 106(18):2372-2378. (Pubitemid 35244740)
55. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176(4):370-376.
56. Gracia-Sancho J, Villarreal G Jr, Zhang Y, Garcia-Cardena G. Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc Res. 2011;85(3):514-519.
57. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8(10):2105-2112.